Dataset Information

Design of a digital beam attenuation system for computed tomography. Part II. Performance study and initial results.

ABSTRACT: The purpose of this work is to present a performance study of the digital beam attenuator (DBA) for implementing fluence field modulated CT (FFMCT) using a simulation framework developed to model the incorporation of the DBA into an existing CT system. Additionally, initial results will be presented using a prototype DBA and the realization of the prototype will be described. To our knowledge, this study represents the first experimental use of a device capable of modulating x-ray fluence as a function of fan angle using a CT geometry.To realize FFMCT, the authors propose to use a wedge design in which one wedge is held stationary and another wedge is moved over the stationary wedge. Due to the wedge shape, the composite thickness of the two wedges changes as a function of the amount of overlap between the wedges. This design allows for the wedges to modulate the photon fluence incident onto a patient. Using a simulation environment, the effect of changing the number of wedges has on dose, scatter, detector dynamic range, and noise uniformity is explored. Experimental results are presented using a prototype DBA having ten Fe wedges and a c-arm CT system geometry. The experimental DBA results are compared to non-DBA scans using scatter and detector dynamic range as metrics. Both flat field and bowtie filtered CT acquisitions were simulated for comparison with the DBA.Numerical results suggest that substantial gains in noise uniformity and scatter-to-primary ratio (SPR) can be obtained using only seven wedges. After seven wedges, the decrease in noise ununiformity and SPR falls off at a lower rate. Simulations comparing CT acquisitions between flat field, bowtie enabled, and DBA CT acquisitions suggest DBA-FFMCT can reduce dose relative to flat field CT by ≈3 times. A bowtie filter under the same imaging conditions was shown to only allow a dose reduction of 1.65 times. Experimentally, a 10 wedge DBA prototype result showed a SPR reduction of ≈4 times relative to flat field CT. The dynamic range for the DBA prototype was 3.7 compared to 84.2 for the flat field scan.Based on the results presented in this paper and the companion paper [T. Szczykutowicz and C. Mistretta, "Design of a digital beam attenuation system for computed tomography. Part I. System design and simulation framework," Med. Phys. 40, 021905 (2013)], FFMCT implemented via the DBA device seems feasible and should result in both a dose reduction and an improvement in image quality as judged by noise uniformity and scatter reduction. In addition, the dynamic range reduction achievable using the DBA may allow photon counting imaging to become a clinical reality. This study may allow for yet another step to be taken in the field of patient specific dose modulation.

SUBMITTER: Szczykutowicz TP

PROVIDER: S-EPMC3562279 | biostudies-other | 2013 Feb

REPOSITORIES: biostudies-other

ACCESS DATA

Similar Datasets

Project description:The purpose of this work is to introduce a new device that allows for patient-specific imaging-dose modulation in conventional and cone-beam CT. The device is called a digital beam attenuator (DBA). The DBA modulates an x-ray beam by varying the attenuation of a set of attenuating wedge filters across the fan angle. The ability to modulate the imaging dose across the fan beam represents another stride in the direction of personalized medicine. With the DBA, imaging dose can be tailored for a given patient anatomy, or even tailored to provide signal-to-noise ratio enhancement within a region of interest. This modulation enables decreases in: dose, scatter, detector dynamic range requirements, and noise nonuniformities. In addition to introducing the DBA, the simulation framework used to study the DBA under different configurations is presented. Finally, a detailed study on the choice of the material used to build the DBA is presented.To change the attenuator thickness, the authors propose to use an overlapping wedge design. In this design, for each wedge pair, one wedge is held stationary and another wedge is moved over the stationary wedge. The composite thickness of the two wedges changes as a function of the amount of overlap between the wedges. To validate the DBA concept and study design changes, a simulation environment was constructed. The environment allows for changes to system geometry, different source spectra, DBA wedge design modifications, and supports both voxelized and analytic phantom models. A study of all the elements from atomic number 1 to 92 were evaluated for use as DBA filter material. The amount of dynamic range and tube loading for each element were calculated for various DBA designs. Tube loading was calculated by comparing the attenuation of the DBA at its minimum attenuation position to a filtered non-DBA acquisition.The design and parametrization of DBA implemented FFMCT has been introduced. A simulation framework was presented with which DBA-FFMCT, bowtie filter CT acquisitions, and unmodulated CT acquisitions can be simulated. The study on wedge filter design concluded that the ideal filter material should have an atomic number in the range of 21-34. Iron was chosen for an experimental relative-tube-loading measurement and showed that DBA-FFMCT scans could be acquired with negligible increases in tube power demands.The basic idea of DBA implemented fluence field modulated CT, a simulation framework to verify the concept, and a filter selection study have been presented. The use of a DBA represents another step toward the ultimate in patient specific CT dose delivery as patient dose can be delivered uniquely as a function of view and fan angle using this device.

Project description:Domestic rabbits are increasing in popularity as household pets; therefore, veterinarians need to be familiar with the most common diseases afflicting rabbits including dental disease. Current diagnostic approaches include gross oral examination, endoscopic oral examination, skull radiography, and computed tomography (CT). Cone beam computed tomography (CBCT), a new oral and maxillofacial imaging modality that has the capability to produce high-resolution images, has not yet been described for use in evaluating dental disease in rabbits. A total of 15 client-owned rabbits had CBCT, oral examination, dental charting, and dental treatment performed under general anesthesia. Images were evaluated using transverse and custom multiplanar (MPR), 3D, and panoramic reconstructed images. The CBCT findings were grouped into abnormalities that could be detected on conscious oral examination vs. abnormalities that could not be detected by conscious oral examination. Potential associations between the two categories were examined by pairwise Fisher's exact test with statistical significance determined by P?<?0.05. The most common findings identified on CBCT images were periodontal ligament space widening (14/15), premolar and molar malocclusion (13/15), apical elongation (13/15), coronal elongation (12/15), inflammatory tooth resorption (12/15), periapical lucency (11/15), moth-eaten pattern of osteolysis of the alveolar bone (9/15), ventral mandibular border contour changes (9/15), and missing teeth (8/15). Of the CBCT abnormalities likely to be observed on oral examination, coronal elongation (detectable on oral examination) was significantly associated with apical elongation (P?=?0.029). There were no other significant associations between CBCT findings that are also clinically detectable and CBCT findings that are not be detectable on oral examination. This suggests that pathology often exists that is not apparent upon oral examination. This study establishes the common CBCT findings associated with dental disease in rabbits and demonstrates the feasibility of this technology to diagnose and plan treatment in dental disorders in this species.

Project description:BackgroundThe future risk of myocardial infarction is commonly assessed using cardiovascular risk scores, coronary artery calcium score, or coronary artery stenosis severity. We assessed whether noncalcified low-attenuation plaque burden on coronary CT angiography (CCTA) might be a better predictor of the future risk of myocardial infarction.MethodsIn a post hoc analysis of a multicenter randomized controlled trial of CCTA in patients with stable chest pain, we investigated the association between the future risk of fatal or nonfatal myocardial infarction and low-attenuation plaque burden (% plaque to vessel volume), cardiovascular risk score, coronary artery calcium score or obstructive coronary artery stenoses.ResultsIn 1769 patients (56% male; 58±10 years) followed up for a median 4.7 (interquartile interval, 4.0-5.7) years, low-attenuation plaque burden correlated weakly with cardiovascular risk score (r=0.34; P<0.001), strongly with coronary artery calcium score (r=0.62; P<0.001), and very strongly with the severity of luminal coronary stenosis (area stenosis, r=0.83; P<0.001). Low-attenuation plaque burden (7.5% [4.8-9.2] versus 4.1% [0-6.8]; P<0.001), coronary artery calcium score (336 [62-1064] versus 19 [0-217] Agatston units; P<0.001), and the presence of obstructive coronary artery disease (54% versus 25%; P<0.001) were all higher in the 41 patients who had fatal or nonfatal myocardial infarction. Low-attenuation plaque burden was the strongest predictor of myocardial infarction (adjusted hazard ratio, 1.60 (95% CI, 1.10-2.34) per doubling; P=0.014), irrespective of cardiovascular risk score, coronary artery calcium score, or coronary artery area stenosis. Patients with low-attenuation plaque burden greater than 4% were nearly 5 times more likely to have subsequent myocardial infarction (hazard ratio, 4.65; 95% CI, 2.06-10.5; P<0.001).ConclusionsIn patients presenting with stable chest pain, low-attenuation plaque burden is the strongest predictor of fatal or nonfatal myocardial infarction. These findings challenge the current perception of the supremacy of current classical risk predictors for myocardial infarction, including stenosis severity. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01149590.

Dataset Information

Design of a digital beam attenuation system for computed tomography. Part II. Performance study and initial results.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets